Induction of apoptotic cell death specifically in rat and human cancer cells by pancratistatin

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 33, Issue 3, 2005, Pages 279-295

  Pandey, Siyaram ^a   Kekre, Natasha ^a   Naderi, Jafar ^a   McNulty, James ^b  

^a UNIVERSITY OF WINDSOR   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Apoptosis; Cancer; DNA fragmentation; Normal human fibroblast

Indexed keywords

CYTOLOGY; DRUG PRODUCTS; LIVING SYSTEMS STUDIES; PATIENT TREATMENT; RADIOTHERAPY; TOXICITY; TUMORS;

APOPTOSIS; CANCER CELLS; DNA FRAGMENTATION; NORMAL HUMAN FIBROBLAST;

CELL CULTURE;

COLCHICINE; ETOPOSIDE; HYMENOCALLIS LITTORALIS EXTRACT; PACLITAXEL; PANCRATISTATIN; PLANT EXTRACT; TAMOXIFEN; UNCLASSIFIED DRUG; VINCA ALKALOID;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; DRUG SPECIFICITY; ENDOTHELIUM CELL; FIBROBLAST; GENOTOXICITY; HUMAN; HUMAN CELL; HYMENOCALLIS LITTORALIS; MICROTUBULE; MUTATION; NONHUMAN; PLANT; RAT;

AMARYLLIDACEAE ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; FIBROBLASTS; HUMANS; ISOQUINOLINES; NEOPLASMS; PACLITAXEL; RATS;

PANCRATIUM LITTORALE;

EID: 23944443367     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIO-200066621     Document Type: Article

References (23)

1. Kerr, J.F., Wyllie, A.H., Currie, A.R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257.
2. Jaattela, M. (2002). Programmed cell death: many ways for cells to die decently. Ann. Med. 34: 480-488.
3. Hu, W., Kavanagh, J.J. (2003). Anticancer therapy targeting the apoptotic pathway. The LANCET Oncology 4: 721-729.
4. Srivastava, R.K. (2001). TRAIL/Apo-21: mechanism and clinical application in cancer. Neoplasia 3: 535-546.
5. Ciardiello, F., Tortora, G. (2001). Inhibition of Bcl-2 as cancer therapy. Ann. Oncol. 13: 501-502.
6. LeBlanc, R., Catley, L.P., Hideshima, T., Lentzsch, S., Mitsiades, C.S., Mitsiades, N., Neuberg, D., Goloubeva, O., Pien, C.S., Adams, J., Gupta, D., Richardson, P.G., Munshi, N.C., Anderson, K.C. (2002). Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model. Cancer Res. 62: 4996-5000.
7. Boose, G., Stopper, H. (2000). Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicology Letters 116: 7-16.
8. Kamineni, P., Prakash, K., Hasan, S.P., Akula, R., Dawkins, F. (2003). Cardiotoxicities of paclitaxel in African Americans. J. Natl. Med. Assoc. 95: 977-981.
9. Cunha, K.S., Reguly, M.L., Graf, U., Helena, H. (2001). Taxanes: the genetic toxicity of paclitaxel and docetaxel in somatic cells of Drosophila melanogaster. Mutagenesis 16: 79-84.
10. Luduena, R.F., Roach, M.C., Prasad, V., Pettit, G.R. (1992). Interaction of dolastin 10 with bovine brain tubulin. Biochemical Pharmacol. 43: 539-543.
11. Pettit, G.R., Pettit, G.R. III, Backhaus, R.A., Boyd, M.R., Meerow, A.W. (1993). Antineoplastic agents 256. Cell growth inhibitory isocarbostyrils from Hymenocallis. J. Nat. Prod. 56: 1682.
12. Morris, H.P. (1965). Studies on the development, biochemistry and biology of experimental hepatomas. Adv. Cancer Res. 9: 227-302.
13. Naderi, J., Hung, M., Pandey, Siyaram. (2003). Oxidative stress-induced apoptosis in dividing fibroblasts involves activation of p38 MAP kinase and over-expression of Bax: Resistance of quiescent cells to oxidative stress. Apoptosis 8: 91-100.
14. Mutsuga, M., Kojima, K., Yamashita, M., Ohno, T., Ogihara, Y., Inoue, M. (2002). Inhibition of cell cycle progression through specific pohase by pancratistatin derivatives. Biol. Pharm. Bull. 25(2): 223-228.
15. Pandey, S., Smith, B., Walker, P.R., Sikorska, M. (2000). Caspase-dependent and independent cell death in rat hepatoma 5123tc cells. Apoptosis 5: 265-275.
16. Reed, J.C. (2002). Apoptosis-based therapies. Nat. Rev. Drug. Discov. 1:111-121.
17. Pandey, S., Wang, E. (1995). Cells en route to apoptosis are characterized by upregulation of c-fos, c-myc, c-jun, cdc-2 and RB-phosphorylation resembling events of early cell-cycle traverse. Journal of Cellular Biochemistry 58: 135-150.
18. Pandey, S., Lopez, C., Jammu, A. (2003). Oxidative stress and activation of proteasome protease during serum deprivation-induced apoptosis in rat hepatoma cells; inhibition of cell death by melatonin. Apoptosis 8: 497-508.
19. Lacour, S., Hammann, A., Wotawa, A., Corcos, L., Solary, E., Dimanche-Boitrel, M.T. (2001). Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Res. 61: 1645-1651.
20. Tolcher, A.W. (2001). Preliminary phase I results of G3139 (bcl-2 antisense oligonucleotide) therapy in combination with docetaxel in hormone-refractory prostate cancer. Semin. Oncol. 28 (4 suppl 15): 67-70.
21. Leung, S., Miyake, H., Zellqeger, T., Tolcher, A., Gleave, M.E. (2001). Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model. Int. J. Cancer 91: 846-850.
22. Henderson, C., Mizzau, M., Paroni, G., Maestro, R., Schneider, C., Brancolini, C. (2003). Role of caspases, bid and p53 in the apoptotic response triggered by histone deacetylase inhibitors TSA and SAHA. J. Biol. Chem. 278:12579-12589.
23. Chun, K.H., Benbrook, D., Berlin, K., Hong, W.K., Lotan, R. (2003). The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway. Cancer Res. 63: 3826-3832.